Kenfarb & Co. Repligen Corp Transaction History
Kenfarb & Co.
- $108 Million
- Q3 2023
A detailed history of Kenfarb & Co. transactions in Repligen Corp stock. As of the latest transaction made, Kenfarb & Co. holds 700 shares of RGEN stock, worth $103,880. This represents 0.1% of its overall portfolio holdings.
Number of Shares
700
Previous 700
-0.0%
Holding current value
$103,880
Previous $99,000
12.12%
% of portfolio
0.1%
Previous 0.09%
Shares
1 transactions
Others Institutions Holding RGEN
# of Institutions
506Shares Held
58.9MCall Options Held
89.3KPut Options Held
679K-
Black Rock Inc. New York, NY7.57MShares$1.12 Billion0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD6.6MShares$980 Million0.09% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.08MShares$753 Million0.01% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct1.91MShares$284 Million0.53% of portfolio
-
State Street Corp Boston, MA1.62MShares$241 Million0.01% of portfolio
About REPLIGEN CORP
- Ticker RGEN
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 55,491,200
- Market Cap $8.23B
- Description
- Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....